Equillium Inc (EQ)

Equillium Inc (EQ) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $83.7M; returns 1 day -3.1%, 1 week +3.4%, 1 year -7.5%.

Equillium Inc (EQ) is a clinical-stage biotechnology company focused on developing immunomodulatory therapies targeting immune cell signaling pathways for treating autoimmune and inflammatory diseases. The company generates minimal revenue currently, primarily from collaboration agreements and small-scale grants, with no approved commercial products as of January 2026.

Groups EQ belongs to

• Biotechnology
• Clinical Stage Biotech
• Clinical Stage
• Healthcare
• Immunotherapy
• Autoimmune Diseases
• Chronic Inflammatory Diseases
• Biopharmaceutical
• Life Sciences

EQ financial model: income statement, cash flow and balance sheet